Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI (AUREA)

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2015 by Hospital de Meixoeiro
Sponsor:
Information provided by (Responsible Party):
Andres Iñiguez Romo, MD, PhD, Hospital de Meixoeiro
ClinicalTrials.gov Identifier:
NCT01642134
First received: June 19, 2012
Last updated: February 24, 2016
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)